Pharmacist HIV/AIDS On-Demand 1.5 credit hours

Pharmacists have successfully managed HIV prevention (PrEP) care for years using oral medications. This on-demand course is designed to expand on this skillset and prepare pharmacists to provide an injectable PrEP medication, lenacapavir. We will review appropriate patient candidates for lenacapavir, discuss landmark clinical trials that led to approval, review important prescribing information, and outline how pharmacists can get paid for their lenacapavir services. After taking this course, pharmacists will be well positioned to provide comprehensive services for patients who would like to access lenacapavir for PrEP in a variety of pharmacy settings.

Learning Objectives

Upon successful completion of this application-based CPE course, pharmacists should be able to:
1. Explain the mechanism of action and unique pharmacokinetic properties of lenacapavir and cabotegravir.
2. Differentiate the target patient populations most likely to benefit from long-acting injectable antiretroviral (LAI-ARV) therapy.
3. Summarize the pivotal clinical trial evidence supporting FDA approval of lenacapavir.
4. Select appropriate laboratory tests for initiation and ongoing monitoring of lenacapavir.
5. Outline essential patient counseling points for both initiation and follow-up visits with lenacapavir.
6. Demonstrate correct injection technique for administering LAI-ARVs.
7. Evaluate available patient assistance programs and pharmacist reimbursement pathways for LAI-ARVs.

Faculty

Elyse Tung, PharmD, BCACP

Director of Clinical Services
Kelley-Ross Pharmacy

Disclosures:

Elyse Tung reports she is a speaker and serves on the advisory board for Gilead Sciences, and serves on the advisory board and received grant funding from Viiv Healthcare Ltd. All relevant financial relationships have been mitigated.

Alexi Duenas, PharmD

Clinical Pharmacist
Kelley-Ross Pharmacy Group

Disclosures:

Alexi Duenas reports she received grant funding from Gilead Sciences. All relevant financial relationships have been mitigated.

Course Details